Author

Sofia Cristóvão‐Ferreira

Instituto Português de Oncologia Francisco GentilORCID 0000-0003-0606-8017Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Approach:experimental assay· 3 Organism:human· 3 Research Focus:differential expression· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Assay:flow cytometry· 1

Frequent Co-Authors

António JacintoiD· 3 shared Bruna Filipa CorreiaiD· 3 shared D.S.C.P. Grosa· 3 shared Maria Guadalupe CabraliD· 3 shared Telma MartinsiD· 3 shared Diana P. SaraivaiD· 2 shared Marina Miguel VitorinoiD· 2 shared Rute M. SalvadoriD· 2 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 44 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

António JacintoORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivPreprintSep 24, 2026

CCR4+low-density neutrophils define a novel immunosuppressive subset associated with breast cancer progression and early mortality

Bruna Filipa Correia, D.S.C.P. Grosa, Rute Salvador…·Maria Guadalupe Cabral

The paper identifies a novel immunosuppressive neutrophil subset, CCR4+LDN, associated with breast cancer progression and mortality, and shows its potential as a biomarker and therapeutic target.

DOI 10.64898/2026.09.22.753474

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologyBreast Cancer ResearchPeer-reviewedDec 19, 2025

Neutrophils matter: New clinical insights on their role in the progression of metastatic breast cancer

Bruna Filipa Correia, D.S.C.P. Grosa, Rute M. Salvador…·Maria Guadalupe Cabral

This study investigates the clinical impact of immunosuppressive low-density neutrophils in metastatic breast cancer, finding they correlate with faster disease progression and reduced survival.

5 citations

humanflow cytometry

𝕏 PostBluesky

ImmunologyFrontiers in ImmunologyPeer-reviewedSep 19, 2025

Enhancing HLA-DR in Cytotoxic T Lymphocytes is crucial for the development of efficient adoptive T cell Therapies for Breast Cancer

Rute M. Salvador, Bruna Correia, D.S.C.P. Grosa…·Maria Guadalupe Cabral

This study shows that enhancing HLA-DR expression in cytotoxic T lymphocytes improves their anti-tumor activity, suggesting strategies to optimize adoptive T cell therapies for breast cancer.

5 citations

humanscRNA-seq

𝕏 PostBluesky